About
Team
Investors
Careers
Investors
Technology
Pipeline
Partnerships
News
Careers
Contact
News
11th December 2020
MTX110 Programmes to be presented at ISPNO 2020
9th December 2020
UK Parliament Highlights Need for New DIPG Treatments
24th November 2020
MTX110 presented at 2020 Annual SNO Conference
27th July 2020
UK Placing to Raise £5.0 million
21st July 2020
Collaboration for the Q-Sphera platform
8th June 2020
Research collaboration with Dr Reddy’s
24th October 2019
Midatech's MTX110 Receives Orphan Designation for DIPG
15th October 2019
Headline Results of MTX110 Phase I DIPG Study
Publications
14th December 2020
High dose MTX110 (soluble panobinostat) safely administered into the fourth ventricle in a …
Download
14th December 2020
1PNOC015: An Open Label Single Arm Study of MTX110 Delivered by Convection-enhanced Delivery (CED) …
Download
14th December 2020
A Phase I study examining the feasibility of intermittent convection-enhanced delivery (CED) of …
Download
24th November 2020
Conlon: Efficacy of soluble panobinostat (MTX110) in preclinical models of adult glioblastoma
Download
24th November 2020
PNOC015: An Open Label Single Arm Study of MTX110 Delivered by Convection-enhanced Delivery (CED) …
Download
1st June 2018
Singleton et al: The distribution, clearance, and brainstem toxicity of panobinostat administered …
Download
18th March 2017
Printing Particles: Printing particles: A high-throughput technique for the production of uniform, …
Download
Other areas
technology
pipeline
partners
×
We are hiring.
View our current vacancies
×